In-silico trials with human modelling and simulation for guiding optimal stratification of atrial fibrillation patients to catheter ablation and pharmacological therapy
<p>Atrial fibrillation (AF) is the most prevalent sustained arrhythmia, affecting over 43 million people worldwide and one in 45 people in the UK. The modest efficacy of currently available therapies adds to the nature of the problem. Antiarrhythmic medication and catheter ablation are the two...
Auteur principal: | Dasí i Martinez, A |
---|---|
Autres auteurs: | Bueno Orovio, A |
Format: | Thèse |
Langue: | English |
Publié: |
2023
|
Sujets: |
Documents similaires
-
In-silico drug trials for precision medicine in atrial fibrillation: From ionic mechanisms to electrocardiogram-based predictions in structurally-healthy human atria
par: Albert Dasí, et autres
Publié: (2022-09-01) -
Virtual In-Silico Modeling Guided Catheter Ablation Predicts Effective Linear Ablation Lesion Set for Longstanding Persistent Atrial Fibrillation: Multicenter Prospective Randomized Study
par: Jaemin Shim, et autres
Publié: (2017-10-01) -
Commentary: Virtual In-Silico Modeling Guided Catheter Ablation Predicts Effective Linear Ablation Lesion Set for Longstanding Persistent Atrial Fibrillation: Multicenter Prospective Randomized Study
par: Axel Loewe, et autres
Publié: (2017-12-01) -
Catheter Ablation for Atrial Fibrillation
par: Andre J. Gauri, et autres
Publié: (2003-10-01) -
Editorial: Atrial fibrillation: insights on mechanisms, mapping and catheter ablation
par: Sergio Conti, et autres
Publié: (2023-09-01)